Cargando…
Silencing growth hormone receptor inhibits estrogen receptor negative breast cancer through ATP-binding cassette sub-family G member 2
Growth hormone receptor (GHR) plays a vital role in breast cancer chemoresistance and metastasis but the mechanism is not fully understood. We determined if GHR could be a potential therapeutic target for estrogen receptor negative (ER−ve) breast cancer, which are highly chemoresistant and metastati...
Autores principales: | Arumugam, Arunkumar, Subramani, Ramadevi, Nandy, Sushmita Bose, Terreros, Daniel, Dwivedi, Alok Kumar, Saltzstein, Edward, Lakshmanaswamy, Rajkumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323053/ https://www.ncbi.nlm.nih.gov/pubmed/30617282 http://dx.doi.org/10.1038/s12276-018-0197-8 |
Ejemplares similares
-
MicroRNA-125a influences breast cancer stem cells by targeting leukemia inhibitory factor receptor which regulates the hippo signaling pathway
por: Nandy, Sushmita Bose, et al.
Publicado: (2015) -
Targeting Insulin-Like Growth Factor 1 Receptor Inhibits Pancreatic Cancer Growth and Metastasis
por: Subramani, Ramadevi, et al.
Publicado: (2014) -
Growth hormone receptor inhibition decreases the growth and metastasis of pancreatic ductal adenocarcinoma
por: Subramani, Ramadevi, et al.
Publicado: (2014) -
Emerging roles of microRNAs in pancreatic cancer diagnosis, therapy and prognosis (Review)
por: SUBRAMANI, RAMADEVI, et al.
Publicado: (2015) -
microRNA alterations in ALDH positive mammary epithelial cells: a crucial contributing factor towards breast cancer risk reduction in case of early pregnancy
por: Bose Nandy, Sushmita, et al.
Publicado: (2014)